Pharmacokinetics and Molecular Docking Studies of Sinapaldehyde and MCM7 Protein against Meier-Gorlin Syndrome

Abstract

Objective: The objective of this study to investigate the MCM7 protein in contrast to Meier-Gorlin Syndrome which contains most of the ORC1, ORC4, ORC6, CDT1, and CDC6 causative genes in the preinitiation complex disruptions. Methods: Sinapaldehyde and MCM7 were retrieved from Protein Data bank and PubChem database in the format of PDB and SDF format. Further, SDF format was converted to PDB format using Biovia Discovery Studio visualizer. Sinapaldehyde was subjected to pharmacoinformatics study as well as Molecular Docking analysis to find out the best anti-Gorlin potential. Results: Sinapaldehyde showed the -5.9kcal/mol binding affinity against MCM7 protein which considers to be a better candidate drug molecule against Meier-Gorlin Syndrome and validated using Pharmacokinetics mechanism. Conclusion: Molecular Docking studies and ADMET analysis showed the inhibitory activity of Sinapaldehyde with respect to Meier-Gorlin Syndrome and related pathway analysis and can be better compound for in vitro studies for future perspectives.